Literature DB >> 32201376

Covid-19 mass testing facilities could end the epidemic rapidly.

Julian Peto1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32201376     DOI: 10.1136/bmj.m1163

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  60 in total

1.  Efficacy of limited antiviral treatment, testing, hospitalization, and social distancing for COVID-19 pandemic.

Authors:  Md Mehadi Hasan; Mostak Ahmed; Suraiya Akter Urmy
Journal:  Sens Int       Date:  2021-06-26

2.  COVID-19 trends, public restrictions policies and vaccination status by economic ranking of countries: a longitudinal study from 110 countries.

Authors:  Myung-Bae Park; Chhabi Lal Ranabhat
Journal:  Arch Public Health       Date:  2022-08-24

Review 3.  Review of Current COVID-19 Diagnostics and Opportunities for Further Development.

Authors:  Yan Mardian; Herman Kosasih; Muhammad Karyana; Aaron Neal; Chuen-Yen Lau
Journal:  Front Med (Lausanne)       Date:  2021-05-07

4.  A Review of COVID-19 Mass Testing in the United Arab Emirates.

Authors:  Farida Al-Hosani; Shereena Al-Mazrouei; Shammah Al-Memari; Zain Al-Yafei; Marília Silva Paulo; Erik Koornneef
Journal:  Front Public Health       Date:  2021-05-12

5.  Lessons Learned From an Analysis of the Emergency Medical Services' COVID-19 Drive-Through Testing Facilities in Israel.

Authors:  Itay Zmora; Evan Avraham Alpert; Uri Shacham; Nisim Mishraki; Eli Jaffe
Journal:  Disaster Med Public Health Prep       Date:  2021-02-16       Impact factor: 1.385

6.  Comparative Study of COVID-19 Pandemic Progressions in 175 Regions in Australia, Canada, Italy, Japan, Spain, U.K. and USA Using a Novel Model That Considers Testing Capacity and Deficiency in Confirming Infected Cases.

Authors:  Choujun Zhan; Chi K Tse; Ying Gao; Tianyong Hao
Journal:  IEEE J Biomed Health Inform       Date:  2021-08-05       Impact factor: 5.772

7.  A Reliable Indirect ELISA Protocol for Detection of Human Antibodies Directed to SARS-CoV-2 NP Protein.

Authors:  Arwa A Faizo; Thamir A Alandijany; Ayman T Abbas; Sayed S Sohrab; Sherif A El-Kafrawy; Ahmed M Tolah; Ahmed M Hassan; Esam I Azhar
Journal:  Diagnostics (Basel)       Date:  2021-05-02

8.  Modelling Analysis of COVID-19 Transmission and the State of Emergency in Japan.

Authors:  Zhongxiang Chen; Zhiquan Shu; Xiuxiang Huang; Ke Peng; Jiaji Pan
Journal:  Int J Environ Res Public Health       Date:  2021-06-26       Impact factor: 3.390

Review 9.  Latest Effective Measures to Combat COVID-19: A Review.

Authors:  Fei Chen; Yingjie Liu; Bailiu Ya; Jiarui He; Taiyang Leng; Yike Sun; Qing Xin
Journal:  Iran J Public Health       Date:  2021-04       Impact factor: 1.429

Review 10.  Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19.

Authors:  Sisay Getu; Tegenaw Tiruneh; Henok Andualem; Wasihun Hailemichael; Teklehayimanot Kiros; Demeke Mesfin Belay; Mulugeta Kiros
Journal:  J Blood Med       Date:  2021-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.